After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Akero Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Akero Therapeutics Inc is $4.11B. A total of 2.14 million shares were traded on the day, compared to an average of 1.41M shares.
In the most recent transaction, Lamy Patrick sold 4,000 shares of AKRO for 50.00 per share on May 22 ’25. After the transaction, the Senior VP, Commercial Strategy now owns 33,492 company shares. In a previous transaction on May 22 ’25, PATRICK D LAMY bought 10,000 shares at 48.35 per share.
Among the insiders who sold shares, Yale Catriona disposed of 10,000 shares on May 15 ’25 at a per-share price of $39.30. This resulted in the Chief Development Officer holding 95,034 shares of AKRO after the transaction. In another insider transaction, CATRIONA YALE bought 30,000 shares at $37.88 per share on May 15 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AKRO has a high of $58.40 and a low of $17.86.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AKRO’s latest balance sheet shows that the firm has $188.26M in Cash & Short Term Investments as of fiscal 2021. There were $1.52M in debt and $25.13M in liabilities at the time. Its Book Value Per Share was $13.60, while its Total Shareholder’s Equity was $169.11M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AKRO is Buy with a score of 5.00.
